Related Experiment Video
Updated: Jun 20, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
The human papillomavirus 16 E2 protein is stabilised in S phase
Cecilia Johansson1, Sheila V Graham, Edward S Dornan
1Institute of Comparative Medicine, University of Glasgow Faculty of Veterinary Medicine, Glasgow, G61 1QH, UK.
Human papillomavirus 16 E2 protein stability and phosphorylation increase during the S phase, optimizing viral DNA replication. Identifying kinases regulating E2 offers therapeutic targets for HPV infections.
Area of Science:
- Virology
- Molecular Biology
- Cell Cycle Regulation
Background:
- The human papillomavirus 16 E2 protein is crucial for viral genome transcription, replication, and segregation.
- E2 interacts with the viral origin of replication and recruits the viral helicase E1 to initiate DNA replication.
Purpose of the Study:
- To investigate the cell cycle regulation of HPV16 E2 protein.
- To identify host cell factors and mechanisms controlling E2 stability and phosphorylation for viral replication.
Main Methods:
- Cell cycle synchronization and analysis.
- Western blotting to assess protein levels and phosphorylation.
- Kinase assays to identify E2-interacting kinases.
Main Results:
- HPV16 E2 protein exhibits increased stability and phosphorylation during the S phase of the cell cycle.
- Preliminary data suggests Cyclin-dependent kinase 2 (Cdk2) phosphorylates E2.
- This S phase-specific modification is linked to enhanced viral DNA replication.
Conclusions:
- E2 stabilization and phosphorylation in S phase are critical for efficient HPV replication.
- Cdk2 is a potential kinase responsible for E2 phosphorylation in vivo.
- Targeting E2-regulating enzymes like Cdk2 could offer novel therapeutic strategies against HPV.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Restarting Stalled Replication Forks
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Inhibition of Cdk Activity

